Quick Answer
CHAMPIONS ONCOLOGY, INC. reported Net Income of $4.70 million for fiscal year 2025.
CHAMPIONS ONCOLOGY, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $4.70M | +164.6% |
| 2024 | -$7.28M | -36.4% |
| 2023 | -$5.33M | -1073.5% |
| 2022 | $548.0K | +51.4% |
| 2021 | $362.0K | +117.3% |
| 2020 | -$2.09M | -1735.2% |
| 2019 | $128.0K | +108.7% |
| 2018 | -$1.48M | +78.6% |
| 2017 | -$6.88M | +34.1% |
| 2016 | -$10.45M | +20.5% |
| 2015 | -$13.14M | -77.4% |
| 2014 | -$7.41M | -17.0% |
| 2013 | -$6.33M | +26.9% |
| 2012 | -$8.66M | -127.8% |
| 2011 | -$3.80M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | -$279.0K | -106.2% | -204.1% |
| October 31, 2025 | $268.0K | -63.2% | +161.5% |
| July 31, 2025 | -$436.0K | -133.2% | -109.7% |
| January 31, 2025 | $4.50M | +277.7% | +517.4% |
| October 31, 2024 | $728.0K | +135.2% | -44.6% |
| July 31, 2024 | $1.31M | +151.2% | +151.9% |
| January 31, 2024 | -$2.53M | -3.7% | -22.2% |
| October 31, 2023 | -$2.07M | -12843.8% | +19.3% |
- CHAMPIONS ONCOLOGY, INC. showed an increase of +164.6% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, CHAMPIONS ONCOLOGY, INC.’s net income has grown by 223.6% (from -$3.80 million to $4.70 million).
- The most recent figure is from CHAMPIONS ONCOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: